Loading...
HSChapter 30
U.S. imports of hormone-containing medicaments (not in dosage form, no antibiotics) (HS 300339) totaled $12.9M in April 2026, traded with 11 countries.
Importers of Hormone-Containing Medicaments (Not in Dosage Form, No Antibiotics) paid $31K in duties in April 2026 — an effective duty rate of 10% on $314K in dutiable value, based on actual customs collections rather than the published tariff schedule. Hormone-Containing Medicaments (Not in Dosage Form, No Antibiotics) imports of $12.9M in April 2026 ran 35% above the year-to-date monthly average of $9.6M.
Last updated: April 2026 dataBulk hormone-based pharmaceutical preparations — including artificial mixtures of natural hormones and other products of HS heading 2937 — enter the US under three distinct tariff lines (3003390000, 3003391000, 3003395000), allowing customs to differentiate synthetic, natural-mixture, and residual hormone formulations at the 10-digit level. Denmark and Belgium lead supply, with India, Italy, and Japan also significant sources, reflecting the global dispersion of active pharmaceutical ingredient (API) and intermediate manufacturing. Because these products are not yet in retail dosage form, they typically move through pharmaceutical supply chains as APIs or semi-finished goods destined for further domestic processing. FDA registration of the foreign establishment and compliance with cGMP standards are mandatory entry requirements.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
The US schedule carves out artificial mixtures of natural hormones into their own 10-digit line (3003391000), separate from the broader catch-all for hormone medicaments (3003395000). The distinction turns on whether the active substance is a defined mixture of naturally occurring hormones versus a synthetic hormone or other product of heading 2937. Importers should confirm the precise chemical identity and mixture composition with their supplier to avoid misclassification.
Certain pharmaceutical intermediates and APIs from China may be subject to Section 301 tariffs depending on the specific product and tariff line. Importers sourcing from China should verify current Section 301 applicability for the relevant 10-digit HTS code before finalizing pricing. Consult a licensed customs broker for the current status of any applicable measures.
Supplier Network
Get discovered by U.S. importers searching for HS 300339 — Hormone-Containing Medicaments (Not in Dosage Form, No Antibiotics). Be the first supplier listed.
Monthly import values over time
HS10 import codes under this HS6 parent. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % | Duty Collected |
|---|---|---|---|---|
| 3003395000 | OTHER MEDICAMENTS CONTAINING HORMONES ETC | $12.2M | 10.00% | $31K |
| 3003391000 | ARTIFICIAL MIXTURES OF NATURAL HORMONES | $703K | -- | -- |
OTHER MEDICAMENTS CONTAINING HORMONES ETC
ARTIFICIAL MIXTURES OF NATURAL HORMONES
HS10 export codes under this HS6 parent. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3003390000 | MEDICAMENT CONT HORMONES OR PROD OF HD 2937 ETC | $30.1M |
MEDICAMENT CONT HORMONES OR PROD OF HD 2937 ETC
41.0K kg
MEDICAMENTS NESOI, MEASURED DOSES, RETAIL PK NESOI
HS 300490
IMMUNOLOGICAL PRODUCTS, IN MEASURED DOESE/RTL SALE
HS 300215
VACCINES FOR HUMAN MEDICINE
HS 300241
HORMONES ETC. (NO ANTIBIOTICS CONTAINED) DOSAGE FM
HS 300439
ANTISERA AND OTHER BLOOD FRACTIONS
HS 300212
IMMUNOLOGICAL PRODUCTS, MIXED, NOT IN MSRED DOSES
HS 300214
| State | Imports | Exports | Balance |
|---|---|---|---|
| Massachusetts | -- | $28.4M | +$28.4M |
| North Carolina | $6.7M | $1.1M | -$5.5M |
| Pennsylvania | $3.8M | $4K | -$3.8M |
| Port | Imports | Exports | Balance |
|---|---|---|---|
| CLEVELAND, OH | -- | $16.3M | +$16.3M |
| LOGAN AIRPORT, MA | -- | $12.3M | +$12.3M |
| NORFOLK-NEWPORT NEWS, VA | $5.1M | -- | -$5.1M |